Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature

BACKGROUND: Hemophagocytic lymphohistiocytosis is becoming an increasingly recognized disorder in adults. Classical Hodgkin lymphoma is a relatively uncommon etiology of hemophagocytic lymphohistiocytosis and may complicate treatment options. Rituximab, etoposide, methylprednisolone, high-dose cytar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Steve, Bansal, Pranshu, Lynch, David, Rojas Hernandez, Cristhiam Mauricio, Dayao, Zoneddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175318/
https://www.ncbi.nlm.nih.gov/pubmed/27998299
http://dx.doi.org/10.1186/s13256-016-1143-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175318/
https://www.ncbi.nlm.nih.gov/pubmed/27998299
http://dx.doi.org/10.1186/s13256-016-1143-9

Ejemplares similares